Fiala, Elise M.
Jayakumaran, Gowtham
Mauguen, Audrey
Kennedy, Jennifer A.
Bouvier, Nancy
Kemel, Yelena http://orcid.org/0000-0002-5042-5651
Fleischut, Megan Harlan
Maio, Anna
Salo-Mullen, Erin E.
Sheehan, Margaret
Arnold, Angela G.
Latham, Alicia
Carlo, Maria I. http://orcid.org/0000-0002-4786-7408
Cadoo, Karen
Murkherjee, Semanti
Slotkin, Emily K.
Trippett, Tanya
Glade Bender, Julia
Meyers, Paul A. http://orcid.org/0000-0001-6146-6101
Wexler, Leonard
Dela Cruz, Filemon S.
Cheung, Nai-Kong http://orcid.org/0000-0001-6323-5171
Basu, Ellen
Kentsis, Alex
Ortiz, Michael
Francis, Jasmine H.
Dunkel, Ira J.
Khakoo, Yasmin
Gilheeney, Stephen
Farouk Sait, Sameer
Forlenza, Christopher J.
Sulis, Maria
Karajannis, Matthias http://orcid.org/0000-0002-7151-6528
Modak, Shakeel
Gerstle, Justin T.
Heaton, Todd E.
Roberts, Stephen
Yang, Ciyu
Jairam, Sowmya
Vijai, Joseph http://orcid.org/0000-0002-7933-151X
Topka, Sabine http://orcid.org/0000-0002-7767-4471
Friedman, Danielle N.
Stadler, Zsofia K.
Robson, Mark http://orcid.org/0000-0002-3109-1692
Berger, Michael F. http://orcid.org/0000-0003-3882-5000
Schultz, Nikolaus
Ladanyi, Marc
O’Reilly, Richard J.
Abramson, David H.
Ceyhan-Birsoy, Ozge
Zhang, Liying http://orcid.org/0000-0003-4517-0751
Mandelker, Diana
Shukla, Neerav N.
Kung, Andrew L.
Offit, Kenneth
Zehir, Ahmet http://orcid.org/0000-0001-5406-4104
Walsh, Michael F. http://orcid.org/0000-0001-5006-6778
Article History
Received: 5 June 2020
Accepted: 7 January 2021
First Online: 15 February 2021
Competing interests
: P.A.M.: Takeda, uncompensated speaking; Amgen, stock ownership; Ipsen, mock ODAC panel; Salarius, mock ODAC panel; P.A.M.’s spouse: Boehringer Ingelheim, consulting; Genentech, speakers’ bureau; Eastern Pulmonary Society. N.K.C. holds ownership interest/equity in Y-mAbs Therapeutics, Inc., reports receiving commercial research grants from Y-mAbs Therapeutics, Inc., and Abpro Labs, Inc., holding ownership interest/equity in Abpro Labs and owning stock options in Eureka Therapeutics, Inc. N.K.C. is a scientific advisory board member of Abpro Labs and Eureka Therapeutics. N.K.C. is the inventor and owner of issued patents licensed by MSK to Y-mAbs Therapeutics, Biotec Pharmacon and Abpro Labs. I.J.D. has done consulting and advisory board activities with Apexigen, AstraZeneca, Bayer, Bristol-Myers Squibb/Celgene, Fennec and Roche. I.J.D. has served as an institutional PI for pharma-sponsored clinical trials at MSKCC from Bristol-Myers Squibb, Genentech and Novartis. M.K. has consultant agreements with AstraZeneca, Bayer, CereXis, QED Therapeutics and Recursion Pharma (personal fees received). S. Modak. is a consultant to Y-mAbs Therapeutics, Inc., Illumina, Inc., and Progenics Pharmaceuticals. Z.K.S.’s immediate family member serves as a consultant for Allergan, Adverum Biotechnologies, Alimera Sciences, Fortress Biotech, Genentech/Roche, Novartis, Optos, Regeneron, Regenxbio and Spark Therapeutics.
Free to read: This content has been made available to all.